Morbihan disease: a therapeutic challenge

AUTOR(ES)

Cabral, Fernanda, Lubbe, Lara Caroline, Nóbrega, Monisa Martins, Obadia, Daniel Lago, Souto, Roberto, Gripp, Alexandre Carlos

FONTE

An. Bras. Dermatol.

DATA DE PUBLICAÇÃO

2017-12

RESUMO

Abstract: Morbihan disease is a rare condition characterized by chronic and persistent erythematous solid edema localized on the face. It is believed to be a complication of rosacea and may occur at any stage of the disease. Features of this condition include variable therapeutic response and great refractoriness. We report a case of a 61-year-old man with rosacea history diagnosed with Morbihan disease, who showed excellent therapeutic response with the combination of deflazacort and oral isotretinoin but developed recurrence after corticosteroid discontinuation. We believe that in severe cases of lymphedema of the face this combination is effective and corticosteroid suspension should be done slowly and gradually.

Documentos Relacionados

• Chagas disease: still a challenge around the World
• Treatment of late Lyme disease: a challenge to accept.
• Genetic diversity and disease: Opportunities and challenge
• Ofuji disease: a rare dermatosis and its challenging therapeutic approach
• Comprehensive healthcare for individuals with sickle cell disease: a constant challenge